Facilitated By

San Antonio Medical Foundation

A PHASE 3b, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS LY2127399 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Escalante,Agustin
Funded by
LILLY RESEARCH LABORATORIES
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Neuroscience